| Trial ID: | L0537 |
| Source ID: | CTRI/2020/03/023814
|
| Associated Drug: |
TurmXtra 60N
|
| Title: |
A randomized, double-blind, multi-center, two-arm, parallel, placebo-controlled study to evaluate the safety and efficacy of TurmXtra 60N (Water dispersible Turmeric extract) capsule 250 mg on Hepatic function markers in subjects with Non Alcoholic Fatty
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
|
| Interventions: |
Intervention1: TurmXtra 60N (Water dispersible Turmeric extract) capsule 250 mg: Dose:250 mg,<br>Frequency:Once Daily, <br>Route of Administration:Oral, <br>Duration of Therapy:84 ???? 2 Days<br><br><br>Control Intervention1: Placebo: NIL<br>
|
| Outcome Measures: |
To assess the efficacy of TurmXtra 60N (Water dispersible Turmeric extract) capsule 250 mg in subjects with NAFLDTimepoint: The primary Outcome will be assessed data obtained on 84 ???? 2 day.To evaluate the safety and tolerability of TurmXtra 60N (Water dispersible Turmeric extract) capsule 250 mg in subjects with NAFLDTimepoint: The secondary Outcome will be assessed data obtained on 84 ???? 2 day.
|
| Sponsor/Collaborators: |
Inventia Healthcare Limited India
|
| Gender: |
--
|
| Age: |
nannan
|
| Phases: |
Not applicable
|
| Enrollment: |
72
|
| Study Type: |
Interventional
|
| Study Designs: |
Randomized, Parallel Group, Placebo Controlled Trial<br> Method of generating randomization sequence:Other Method of allocation concealment:Pre-numbered or coded identical Containers Blinding and masking:Participant, Investigator, Outcome Assessor and
|
| Start Date: |
06/03/2020
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
24 November 2021
|
| Locations: |
India
|
| URL: |
http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=41556
|
